View drug registration information details.
Items | Registration information |
ID | 657 |
No | 657 |
Brand Name | XANILO 30 MG DDR CAPSULE |
Ingredients | DEXLANSOPRAZOLE DUAL DELAYED RELEASE PELLETS EQ.TO DEXLANSOPRAZOLE 30 MG |
Dosage Form | CAPSULE |
Primary Packaging | ALU-ALU BLISTER |
Storage | STORE BELOW 30 C |
Shelf Life | 24 MONTHS |
Pack Size | BOX OF 3 X 10'S |
Dispensing Category | Prescription only |
ATC Classification | |
Pharmaceutical Class | DRUG RELATED TO ACID DISOEDER |
Indications | • Healing of Erosive Esophagitis
Xanilo is indicated in patients 12 years of age and older for healing of all grades of erosive esophagitis (EE) for up to eight weeks.
•Maintenance of Healed Erosive Esophagitis and Relief of Heartburn
Xanilo is indicated in patients 12 years of age and older to maintain healing of EE and relief of heartburn for up to six months in adults and 16 weeks in patients 12 to 17 years of age.
• Treatment of Symptomatic Non-Erosive Gastroesophageal Reflux Disease
Xanilois indicated in patients 12 years of age and older for the treatment of heartburn associated with symptomatic non-erosive gastroesophageal
reflux disease (GERD) for four weeks. |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
No |
Description | Hard HPMC capsule size #3, light blue opaque cap and iron grey opaque body, containing off white to light brownish colored, dual delayed released spherical pellets |
Note | ONLINE |
License Owner | EXAMED CO.,LTD |
Manufacturer | MARTIN DOW LTD |
Country | PAKISTAN |
Import Registration No | 108828 |
Import Registration Date | 2021-07-30 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2024-07-19 |
FDD Registration No | 01 I 5857/25 |
FDD Registration Date | 2025-01-23 |
Expiry Date | 2030-01-22 |
Back to drug list
|